<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0" xmlns:cc="http://cyber.law.harvard.edu/rss/creativeCommonsRssModule.html">
    <channel>
        <title><![CDATA[Stories by Sarah Reed on Medium]]></title>
        <description><![CDATA[Stories by Sarah Reed on Medium]]></description>
        <link>https://medium.com/@sarahbreed01?source=rss-28ce01583504------2</link>
        <image>
            <url>https://cdn-images-1.medium.com/fit/c/150/150/1*vMSH2IjWwmrljBareOeGIg.jpeg</url>
            <title>Stories by Sarah Reed on Medium</title>
            <link>https://medium.com/@sarahbreed01?source=rss-28ce01583504------2</link>
        </image>
        <generator>Medium</generator>
        <lastBuildDate>Sat, 21 Nov 2026 19:23:57 GMT</lastBuildDate>
        <atom:link href="https://medium.com/@sarahbreed01/feed" rel="self" type="application/rss+xml"/>
        <webMaster><![CDATA[yourfriends@medium.com]]></webMaster>
        <atom:link href="http://medium.superfeedr.com/" rel="hub"/>
        <item>
            <title><![CDATA[Why D3 is So Hard To Learn from Bl.ocks]]></title>
            <link>https://medium.com/nightingale/why-d3-is-so-hard-to-learn-from-bl-ocks-a2ac258964af?source=rss-28ce01583504------2</link>
            <guid isPermaLink="false">https://medium.com/p/a2ac258964af</guid>
            <category><![CDATA[data-visualization]]></category>
            <category><![CDATA[javascript]]></category>
            <category><![CDATA[d3js]]></category>
            <category><![CDATA[learning]]></category>
            <dc:creator><![CDATA[Sarah Reed]]></dc:creator>
            <pubDate>Wed, 11 Sep 2019 16:09:02 GMT</pubDate>
            <atom:updated>2019-09-11T16:09:02.849Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*F7H9niT-bi1h7IH8p3y86g.png" /><figcaption>Hard at work in the D3 mines</figcaption></figure><h3>Why is D3 So Hard To Learn From Bl.ocks?</h3><h4>Tantalizingly complete, the current state of blocks leads to confusion and poor coding technique.</h4><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*1KEHDw84XTLaW7ga0CAxbw.png" /><figcaption>Comments Save Brains</figcaption></figure><p>As an early career practitioner, I’m drawn to D3 by the compelling graphics I’ve seen users produce with it, as well as its interactivity. As a former mechanical engineer, my nature is to want to play with and manipulate things. D3 is often touted as the only way to make the most powerful data visualization products. But one of the main ways of learning D3 is “by example” (see Mike Bostock’s 2013 Eyeo talk <a href="https://vimeo.com/channels/544709/69448223">“For Example”</a>) and those examples are typically hosted as gists on GitHub and then deployed using Mike’s own code called <a href="http://bl.ocks.org/">bl.ocks.org</a> (typically referred to as “blocks”) or via similar methods like blockbuilder. Bostock’s new endeavor, <a href="https://observablehq.com/">Observable</a>, is populated with many new examples that also follow the same approach as these original blocks.</p><p>I want to start off by thanking him for creating D3. It’s an incredible tool and I very much look forward to feeling competent in my use of it.</p><p>Unfortunately, these blocks he created show major issues that can subvert a learner’s ability to understand code. Or maybe they started that way? I’m new enough to D3 to not know the origin story of these things. Did they start as innocuous ramblings from Bostock as he played with the magical toy he had just invented? Did he intend for them to become the go-to tool for learning how to use said magical toy? Did he ever imagine how many hours would be spent by future disciples helplessly trying to decode not only his wholly un-commented work but the un-commented, and frequently wrong, work of others?</p><p>I like to think that it was the innocuous ramblings option. That way I can excuse Bostock and those that came after him from culpability in my personal frustration as I learn his tool.</p><p>Here’s an example of a fun viz that would be so much more useful to us newbies if it had some comments.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*JYgTJ_rftaTn20CSEY7srg.png" /><figcaption><a href="https://bl.ocks.org/mbostock/3231298">https://bl.ocks.org/mbostock/3231298</a></figcaption></figure><pre>&lt;!DOCTYPE html&gt;<br>&lt;meta charset=&quot;utf-8&quot;&gt;<br>&lt;body&gt;<br>&lt;script src=&quot;//d3js.org/d3.v3.min.js&quot;&gt;&lt;/script&gt;<br>&lt;script&gt;<br><br>var width = 960,<br>    height = 500;<br><br>var nodes = d3.range(200).map(function() { return {radius: Math.random() * 12 + 4}; }),<br>    root = nodes[0],<br>    color = d3.scale.category10();<br><br>root.radius = 0;<br>root.fixed = true;<br><br>var force = d3.layout.force()<br>    .gravity(0.05)<br>    .charge(function(d, i) { return i ? 0 : -2000; })<br>    .nodes(nodes)<br>    .size([width, height]);<br><br>force.start();<br><br>var svg = d3.select(&quot;body&quot;).append(&quot;svg&quot;)<br>    .attr(&quot;width&quot;, width)<br>    .attr(&quot;height&quot;, height);<br><br>svg.selectAll(&quot;circle&quot;)<br>    .data(nodes.slice(1))<br>  .enter().append(&quot;circle&quot;)<br>    .attr(&quot;r&quot;, function(d) { return d.radius; })<br>    .style(&quot;fill&quot;, function(d, i) { return color(i % 3); });<br><br>force.on(&quot;tick&quot;, function(e) {<br>  var q = d3.geom.quadtree(nodes),<br>      i = 0,<br>      n = nodes.length;<br><br>  while (++i &lt; n) q.visit(collide(nodes[i]));<br><br>  svg.selectAll(&quot;circle&quot;)<br>      .attr(&quot;cx&quot;, function(d) { return d.x; })<br>      .attr(&quot;cy&quot;, function(d) { return d.y; });<br>});<br><br>svg.on(&quot;mousemove&quot;, function() {<br>  var p1 = d3.mouse(this);<br>  root.px = p1[0];<br>  root.py = p1[1];<br>  force.resume();<br>});<br><br>function collide(node) {<br>  var r = node.radius + 16,<br>      nx1 = node.x - r,<br>      nx2 = node.x + r,<br>      ny1 = node.y - r,<br>      ny2 = node.y + r;<br>  return function(quad, x1, y1, x2, y2) {<br>    if (quad.point &amp;&amp; (quad.point !== node)) {<br>      var x = node.x - quad.point.x,<br>          y = node.y - quad.point.y,<br>          l = Math.sqrt(x * x + y * y),<br>          r = node.radius + quad.point.radius;<br>      if (l &lt; r) {<br>        l = (l - r) / l * .5;<br>        node.x -= x *= l;<br>        node.y -= y *= l;<br>        quad.point.x += x;<br>        quad.point.y += y;<br>      }<br>    }<br>    return x1 &gt; nx2 || x2 &lt; nx1 || y1 &gt; ny2 || y2 &lt; ny1;<br>  };<br>}<br><br>&lt;/script&gt;</pre><p>In the example above, wouldn’t it be great to have a brief explanation of what the map method is doing? Or what do .gravity and .charge do? These, of course, are things that can be looked up in the<a href="https://github.com/d3/d3/blob/master/API.md"> D3 API</a> but a brief explanation specific to this chart would be much more efficient.</p><p>I’ve been learning D3 on and off now for about a year and a half. I’ve gone through some tutorials but I find that they only scratch the surface and are often fragmented — learning the code for building a scale doesn’t mean anything to me without the accompanying chart. Also, I’m impatient. Once I built my first simple bar chart I wanted to do all of it. And all of it was sitting right there in the block library! Beautiful, interactive charts that just looked so cool. And all the code was sitting there for me to use!</p><p>So, my process has generally been the following:</p><ol><li>Decide what kind of chart I want to make</li><li>Search for a block demonstrating that chart</li><li>Attempt to modify the block to ingest my own data and fit my own needs.</li></ol><p>This is where things go wrong. Without comments and explanations of what is happening along the way, it’s very hard for someone starting out to figure out what’s going on. Where in this code is the data ingested? How is it manipulated? Why is it manipulated? And why isn’t it working with my data?</p><p>And then there’s the problem of blocks that are written with bad code, or don’t include the necessary data files or libraries. I run a dataviz meetup near me and part of what we’ve been doing each month is to dig through a block to understand what’s going on. We’ve come across:</p><ul><li>Redundant code. This is where the writer wasn’t sure which was the best method to accomplish their task so they just used both. How is a newbie supposed to recognize this?</li><li>Blocks that don’t include all the necessary data files. The only way to recreate a block is to have the data it worked with. Without that it’s useless.</li><li>Blocks that are disorganized. This is a stylistic issue and one I could live with but it’s worth mentioning.</li></ul><p>Blocks today seem to be simply a showpiece. A way to get someone’s work up in front of other people. They’re not written or intended to be helpful or useful in the pursuit of learning D3. I should also say, aside from HTML and CSS, this is the first coding language I’ve learned so I don’t know if my experience with D3 is unique to this language or just the way it’s done in learning to code.</p><h3>What can we do to fix this?</h3><p>In writing this article I’ve stumbled upon some maybe useful articles and tutorials that I wish I had read through as I was starting out (but I’m impatient). The <a href="https://github.com/d3/d3/wiki/Tutorials">D3 Tutorials Github</a> Repo appears to have some more comprehensive information.</p><p>I, myself, have been working to comment any block I dig through and fix bad code. I hope others will join me. I’ve only gotten a few done but every little bit helps.</p><ul><li>Comment your blocks. Write nice long intros that explain what the block does and any challenges you had. Especially comment on any data binding peculiarities.</li><li>Include any data files that are needed for the block. That should go without saying.</li><li>Include links to any additional libraries you used.</li><li>Make note, ideally in the title but at least in the intro, what version you used to create the block. Versions matter a lot.</li><li>Write an awesomely detailed account of how you created your thing like <a href="https://link.medium.com/IRuAnYuBSZ">this guy.</a></li></ul><p>Overall, try to remember what it was like when you were learning this tool and think back to what might have helped you as you sat mystified at your desk. When I first started learning this tool I thought it was so cool that there were all these great examples for me to work off of. A year and a half into it, now, the tool is finally starting to gain some transparency. I wonder how much faster that could have happened if those examples had been easier to understand.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=a2ac258964af" width="1" height="1" alt=""><hr><p><a href="https://medium.com/nightingale/why-d3-is-so-hard-to-learn-from-bl-ocks-a2ac258964af">Why D3 is So Hard To Learn from Bl.ocks</a> was originally published in <a href="https://medium.com/nightingale">Nightingale</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Costs of Breast Cancer]]></title>
            <link>https://medium.com/@sarahbreed01/costs-of-breast-cancer-3d1493db30bb?source=rss-28ce01583504------2</link>
            <guid isPermaLink="false">https://medium.com/p/3d1493db30bb</guid>
            <category><![CDATA[breast-cancer]]></category>
            <category><![CDATA[family]]></category>
            <category><![CDATA[women]]></category>
            <category><![CDATA[healthcare]]></category>
            <category><![CDATA[insurance]]></category>
            <dc:creator><![CDATA[Sarah Reed]]></dc:creator>
            <pubDate>Tue, 16 Oct 2018 22:02:00 GMT</pubDate>
            <atom:updated>2018-10-16T22:02:00.421Z</atom:updated>
            <content:encoded><![CDATA[<h3>The emotional and physical toll of Breast Cancer is well known…</h3><p>But what about the financial impact? A diagnosis of cancer is associated with a <a href="http://www.nbcnews.com/id/51893912/ns/health-cancer/t/cancer-increases-bankruptcy-risk-even-insured/#.Wh75y0trzOQ">2.65 times</a> increased risk of bankruptcy. How can a person heal effectively when they’re worried how they’ll pay for their treatment or if they’re going to lose their health insurance? <br> <br> And if they survive the cancer but end up broke, are they really healed?</p><p>The financial impacts associated with breast cancer, and other cancers alike, effect all patients but are especially impactful on the lower middle class. They are a portion of the population who earn too much to be covered by medicaid but don’t earn enough to have the savings necessary to weather the costs and financial losses associated with a drawn out treatment regimen. With heath insurance tied to their jobs, a job loss during treatment- either related to the illness or simply bad timing- can cause a financial spiral into bankruptcy.</p><p>Even with insurance intact, the additional costs associated with being sick, such as over the counter medication, wigs, etc., coupled with lost wages from having to take time off for treatment and rest, can quickly deplete a family’s meager savings to zero.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*Wy_7cgv1e6wznMvpVm1sVQ.png" /><figcaption>This bill was sent to me by a woman I interviewed for this article. It’s for just three weeks of her treatment. While the bottom line indicates that she’s only responsible for $17.65, were her husband to lose his employer sponsored insurance, they would be responsible for the entire amount.</figcaption></figure><p>The skyrocketing costs of pharmaceuticals are a major culprit in the financial burden to the patient. Cancer pharmaceuticals are getting steadily more expensive but the improvements in life expectancy are not nearly keeping pace. In a study of 71 drugs to treat solid tumors the median improvement in progression free survival was just 2.3 months. Pharmaceutical companies claim that they need the extra income for R&amp;D yet regularly pocket double digit profits greater than the finance industry. The money they do reinvest in the company usually ends up more in marketing budgets than R&amp;D budgets. Pharmaceutical companies, instead, rely on government funding for R&amp;D.</p><p>The fear and stress associated with the financial impacts of the disease affect nearly all patients. Stress is well known to inhibit healing. Employer tied health insurance coupled with skyrocketing costs of medicine lead to a toxic financial situation for patients and their families.</p><p>To look at this problem more carefully we’ll follow the course of treatment for a woman I’ve created as a conglomerate of women I interviewed for this story.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*xj3xmwBAz_xKrEFGmk2NiA.png" /></figure><p>Karina and Tom live in Florida and have two kids ages 10 and 14. Karina is 45 and works part time in administration at a Law Firm. The other half of her time she’s taking care of her kids, volunteering with local organizations and caring for her aging mother. <br> <br>Tom is 43 years old and works as an engineer at a construction company. Construction is down lately and he’s been worried he may loose his job. His company just had company-wide paycuts due to the downturn. He’s been thinking of trying to find another job.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1000/1*59zTtV5loIJB_ww5OoTSbA.png" /></figure><p>This is Karina and Tom’s pre-illness budget breakdown. Tom makes a good wage and they have managed to keep their expenses low. They tend to spend their remaining money on travel and leisure activities.</p><h3>Diagnosis</h3><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*USOJUsIWZ4M26Vfa9io7_g.png" /></figure><p>Breast Cancer rates among older women fell in the early 2000s but have lately started to rise again. <br> Rates for younger women have stayed unfortunately level. At 45 years old, 123 out of 100,000 women will develop breast cancer.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*vn-QKfNN_GYSR-_-NpzNog.png" /></figure><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*OQKh9uARKD3hXtwRwuRa8Q.png" /></figure><figure><img alt="" src="https://cdn-images-1.medium.com/max/1000/1*R6JJn91i5aOleLdJm2i1Kg.png" /></figure><figure><img alt="" src="https://cdn-images-1.medium.com/max/1010/1*1ldc8KIyEsfHX5M03NBcKA.png" /></figure><figure><img alt="" src="https://cdn-images-1.medium.com/max/1010/1*yZ_wQRal_aUm5jO98qvj4A.png" /></figure><h3>Insured Rates among Americans in 2016</h3><p>Nearly half of all American’s insurance is tied to their workplace. Insurance plans vary significantly from one to the next. Further, Medicare and Medicaid also differ in how they cover the costs of cancer. Astonishingly, 9% of all Americans had no insurance coverage in 2016. That’s 28 Million people who would need to pay out of pocket for their cancer treatment.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*VIpKKcig7AH7_kSttCnsyg.png" /></figure><p>Karina and Tom are lucky enough to have insurance through his job for now. They pay $4,378 per year in premiums and have a $2,811 deductible. They are also responsible for the various copayments the insurance company requires each time they see a doctor. While they were both working, they could afford this amount without much struggle. But now that Karina is sick she’s had to cut back on her hours and there are more expenses. Their insurance plan has a life-time cap on out-of-pocket expenses but that doesn’t cover the:</p><ul><li>Travel</li><li>Nonprescription medications</li><li>Extra childcare</li><li>Lost wages</li><li>Special Diets</li><li>Wigs and prosthetics</li></ul><figure><img alt="" src="https://cdn-images-1.medium.com/max/1000/1*io1HPaM0Wdj7Dn0_KvNaOA.png" /></figure><p>This is Karina and Tom’s budget breakdown now that she has cut back on her work and with her added medical expenses.</p><h3>Do Americans Have Enough In Savings to Cover the Costs of Cancer?</h3><p>The overall cost to a patient and her family <br> varies dramatically depending on</p><ul><li>Insurance Status</li><li>Location</li><li>Race</li><li>Stage and Type of Cancer</li></ul><p>A <a href="http://ascopubs.org/doi/full/10.1200/jco.2013.53.0956">study</a> of women with breast cancer in LA from 2005 to 2007, who had health insurance of some kind, found:</p><p>35% had out of pocket expenses greater than $2000</p><p>12% reported increased debt due to their treatment</p><p>5% had their utilities turned off because of upaid bills</p><p>In 2017 the average American had less than $1000 in savings. <br> Karina and Tom, like 57% of Americans, have very little in savings. They currently have just under $1000 in savings and were hoping to start putting away more as their kids get closer to college.The added health care expenses they experience will need to be paid for out of his wages, her reduced hours and, likely, debt.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1008/1*ljibG3NcZU8XHwrRsdNr8A.png" /></figure><h3>Financial Assistance</h3><p>Many hospitals have a Counselor who meets with patients to help them deal with the emotional and financial burdens of their cancer treatment.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*Qf1z5ZzGdTJMDlHUEWo-3Q.png" /></figure><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*WkqQENenpx-n7pVVjMHJ0A.png" /></figure><figure><img alt="" src="https://cdn-images-1.medium.com/max/897/1*qr4hJeevXqUvFapnm44Mww.png" /></figure><p>In a <a href="http://ascopubs.org/doi/full/10.1200/jco.2013.53.0956">study</a> of breast cancer patients, 53% reported that it was important to avoid changing jobs because of worry about losing health insurance. 25% said they would look for a new job only if they could be assured of comparable benefits.</p><p>Counselors help patients find charitable donations- a lifeline for many patients. Even those with insurance, often need help to cover the added costs of the disease, that are not covered by insurance, like extra childcare, help with housekeeping, lost wages for time they had to take off work, etc.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*RLQitcScxIkrwsDTjBNhEg.png" /></figure><figure><img alt="" src="https://cdn-images-1.medium.com/max/812/1*gF_zoWKyDQ6fBWUvPwhyvw.png" /></figure><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*fHZfkrmLMhfaunlDzzm-AA.png" /></figure><p>While receiving her chemo treatment, Karina must use the time to fill out applications to charitable organizations for financial aid.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1004/1*ixERomZh0lcQ9KhVpQZOuw.png" /></figure><h3>The Cost of Pharmaceuticals</h3><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*kAhKgH9z2cIROpSVXq6ZxQ.png" /></figure><h3>Financial Coping Mechanisms</h3><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*2hdvnTwj4aTmMs3uFKPT2g.png" /></figure><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*TRfEq5uVm6MTybVbbw17tg.png" /></figure><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*wtCjxUEj8WK0czdCTBSMnQ.png" /></figure><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*vnm5PGKo-JJ5fPAU7ztUmQ.png" /></figure><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*t1T3vCTef8dqUhK9BO8tuQ.png" /></figure><p>Karina and Tom will need to either stay on Cobra insurance or shop for insurance on the exchange under the Affordable Care Act. If they elect to stay on Cobra they will be responsible for the full $16,009 <a href="http://www.commonwealthfund.org/publications/issue-briefs/2016/oct/slowdown-in-employer-insurance-cost-growth">annual premium</a> that Tom’s employer used to pay. Cobra will also only cover them for <a href="https://www.blr.com/HR-Employment/Benefits-Leave/COBRA-Health-Insurance-Continuation-in-Florida">18 months.</a> <br> <br> Under the Affordable Care Act they, luckily, cannot be denied insurance on the open market because of Karina’s pre-existing condition. If they do decide to look for insurance on the insurance exchange in Florida, however, they will be in for $555 per month for the premiums for a <a href="https://www.kff.org/interactive/subsidy-calculator/#state=fl&amp;zip=32218&amp;income-type=dollars&amp;income=20000&amp;employer-coverage=0&amp;people=4&amp;alternate-plan-family=individual&amp;adult-count=2&amp;adults%5B0%5D%5Bage%5D=45&amp;adults%5B0%5D%5Btobacco%5D=0&amp;adults%5B1%5D%5Bage%5D=43&amp;adults%5B1%5D%5Btobacco%5D=0&amp;child-count=2&amp;children%5B0%5D%5Bage%5D=10&amp;children%5B0%5D%5Btobacco%5D=0&amp;children%5B1%5D%5Bage%5D=14&amp;children%5B1%5D%5Btobacco%5D=0">middle of the road plan</a>. Additionally they will need to cover the $4,000 deductible plus the $11,700 out-of-pocket limit for the year. This is after the subsidies provided under the ACA. <br> <br> Tom’s unemployment will <a href="https://eligibility.com/unemployment/florida-fl">max out</a> at $1,100 per month.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1012/1*WXFJ0yWnB6B-DY95Mmn28A.png" /></figure><p>This is Karina and Tom’s budget breakdown now that Tom is out of work. His unemployment income doesn’t come close to covering their expenses now. They’ve done what they can to cut back but there’s only so much they can cut back on at this point. They’re now $2,698 under water each month.</p><p>Their meager savings are shot. Tom’s out of work. Karina’s going to need to stay home to recover from her double mastectomy and reconstruction. What do they do?</p><p>Women, and their families, deal with the financial burden of treatment in different ways depending on their situation. All the coping mechanisms are impactful on the patient and her family and distract from the real work of healing and surviving.</p><p>Some common ways that women and their families cope are:</p><ul><li>Obtain samples from doctor</li><li>Shop around at pharmacies for the lowest prices</li><li>Spread out clinic or chemo appointments</li><li>Ask doctor for less expensive medication</li><li>Purchase over-the-counter medications to replace prescriptions</li><li>Reduce spending on basics like food and clothing</li><li>Borrow money or use credit to pay for medications</li><li>Use all or a portion of savings to pay for cancer care</li><li>Fill only part of the prescription</li><li>Choose one doctor over another for price</li><li>Decide not to have recommended test</li><li>Reduce spending on leisure activities like vacations, eating out or movies</li><li>Don’t fill the prescription</li></ul><p>Failing to adhere to the recommended treatment program can reduce its efficacy and prolong the disease. Rest and leisure activities during and after cancer treatment should not be a luxury and are critical to reducing stress which is <a href="http://www.apa.org/helpcenter/stress.aspx">correlated</a> with improved health.</p><h3>So, what happens to Karina and Tom?</h3><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*xj3xmwBAz_xKrEFGmk2NiA.png" /></figure><p>Karina and Tom are a fictional couple, but they are based on real women and their families. Millions of women and their families face this question every day. Do they go into debt? Do they sell their house? Do they declare bankruptcy? <br> <br> <strong>What would you do?</strong> <br> <br> Karina will survive her bout with cancer. She will recover physically but the cancer could still come back any time. As long as their insurance is tied to their jobs, Karina and Tom’s careers will be inextricably linked to the need for health insurance. As long as the ever increasing costs of pharmaceuticals are passed onto the insurance consumer, Karina and Tom will not likely be able to afford insurance on the private market.</p><h3>Solutions</h3><p>There are many factors that contribute to the financial impact of breast cancer. Policy solutions have been proposed to address a variety of them.</p><h3>The Cost of Medications</h3><p>The lion’s share of cost to treat breast cancer comes down to the cost of medications. Pharmaceutical companies use the patents they hold on the cancer medications to protect the prices they charge.</p><p>Extensive research has been conducted to study how to reduce the stranglehold while continuing to encourage innovation</p><p>Some solutions that have been proposed are:</p><ul><li><a href="http://delinkage.org/">Delinkage</a></li><li><a href="https://www.innovationpolicyplatform.org/content/patent-pools-and-antitrust">Patent Pooling</a> (watch a great video about it <a href="https://www.ted.com/talks/ellen_t_hoen_pool_medical_patents_save_lives">here</a>)</li><li>Allow Medicare to negotiate drug prices as Medicaid and all other insurance companies are allowed to</li><li>Allow drugs to be imported from countries where they are sold at reduced prices</li><li>Find even more information about the issue of pharmaceutical patents <a href="http://accesstomedicines.org/access-to-medicines">here</a></li></ul><h3>Health Insurance</h3><p>As with the cost of pharmaceuticals, the issue of health insurance is complicated. Throughout this research, however, two questions consistently floated to the top.</p><p>Why should a person fighting to survive cancer feel that they have to work just to keep their insurance?</p><p>Why should your health be tied to your job?</p><p>A solution to this problem is universal healthcare (single-payer)- health insurance provided by the goverment to all citizens. All citizens are, therefore, guaranteed the right to healthcare. This would allow the the government to negotiate with pharmaceutical companies as one large block instead of individual health insurers negotiating piecemeal. The government already negotiates with the pharmaceutical companies through Medicaid but at a much smaller volume. Pharmaceuticals are <a href="https://jamanetwork.com/journals/jama/article-abstract/2674647?redirect=true">significantly more expensive </a>in the United States than in other countries where healthcare is universal. <br> <br> Learn more about universal healthcare <a href="http://www.healthpaconline.net/universal-health-care.htm">here</a> or <a href="http://www.pnhp.org/facts/what-is-single-payer">here</a>. <br> Learn more about how America is the only industrialized country without single-payer healthcare <a href="https://www.theatlantic.com/international/archive/2012/06/heres-a-map-of-the-countries-that-provide-universal-health-care-americas-still-not-on-it/259153/">here.</a></p><h3>What can you do?</h3><p>Contact your elected officials and call for more consideration of the solutions listed here. It’s only through the voice of the citizens that the elected officials are guided on the right path.</p><p>Find out how to contact your elected officials <a href="http://act.commoncause.org/site/PageServer?pagename=sunlight_advocacy_list_page">here</a></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=3d1493db30bb" width="1" height="1" alt="">]]></content:encoded>
        </item>
    </channel>
</rss>